These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 23682212)
1. A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy. Wattmo C; Paulsson E; Minthon L; Londos E Clin Interv Aging; 2013; 8():329-39. PubMed ID: 23682212 [TBL] [Abstract][Full Text] [Related]
2. Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort. Wattmo C; Wallin AK; Minthon L BMC Neurol; 2012 Nov; 12():134. PubMed ID: 23126532 [TBL] [Abstract][Full Text] [Related]
3. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease. Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574 [TBL] [Abstract][Full Text] [Related]
6. BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors. Chianella C; Gragnaniello D; Maisano Delser P; Visentini MF; Sette E; Tola MR; Barbujani G; Fuselli S Eur J Clin Pharmacol; 2011 Nov; 67(11):1147-57. PubMed ID: 21630031 [TBL] [Abstract][Full Text] [Related]
7. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Wattmo C; Minthon L; Wallin ÅK Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213 [TBL] [Abstract][Full Text] [Related]
8. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting. Aguglia E; Onor ML; Saina M; Maso E Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474 [TBL] [Abstract][Full Text] [Related]
9. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment. Wattmo C; Wallin ÅK; Londos E; Minthon L Alzheimer Dis Assoc Disord; 2011; 25(1):63-72. PubMed ID: 20847636 [TBL] [Abstract][Full Text] [Related]
11. Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease. Scacchi R; Gambina G; Broggio E; Corbo RM Int J Geriatr Psychiatry; 2014 Jun; 29(6):610-5. PubMed ID: 24150894 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study. Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427 [TBL] [Abstract][Full Text] [Related]
14. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services. Wattmo C; Londos E; Minthon L Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578 [TBL] [Abstract][Full Text] [Related]
15. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period. López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Takeda A; Loveman E; Clegg A; Kirby J; Picot J; Payne E; Green C Int J Geriatr Psychiatry; 2006 Jan; 21(1):17-28. PubMed ID: 16323253 [TBL] [Abstract][Full Text] [Related]
17. Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review. Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N Int J Technol Assess Health Care; 2002; 18(3):497-507. PubMed ID: 12391943 [TBL] [Abstract][Full Text] [Related]
18. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Thompson S; Lanctôt KL; Herrmann N Expert Opin Drug Saf; 2004 Sep; 3(5):425-40. PubMed ID: 15335298 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Alzheimer's disease in the long-term-care setting. Smith DA Am J Health Syst Pharm; 2009 May; 66(10):899-907. PubMed ID: 19420308 [TBL] [Abstract][Full Text] [Related]
20. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease? Isik AT; Bozoglu E; Yay A; Soysal P; Ateskan U Am J Alzheimers Dis Other Demen; 2012 May; 27(3):171-4. PubMed ID: 22573283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]